4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Acute Lymphocytic Leukemia: new trials by email Literature Review of Acute Lymphocytic Leukemia trials Research Report on Acute Lymphocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Cyclophosphamide, Tacrolimus, Mycophenolate mofetil - Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Terminated | Loyola University | 5 | 2017-01-18 | 2024-07-10 |
| Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma DNR, VCR, PEG-asp - Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma | Phase 2 | Terminated | University of California, San Diego | 31 | 2014-01-01 | 2022-05-02 |
| Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies CliniMACS® CD34 Reagent System, Fludarabine, Melphalan - Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Terminated | Weill Medical College of Cornell University | 2 | 2012-10-26 | 2018-07-11 |
| Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match Busulfan, Clofarabine, Fludarabine - Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Terminated | Texas Oncology Cancer Center | 1 | 2011-11-01 | 2013-11-25 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Leukemia, Myeloid, Acute (3) · Lymphoma, Non-Hodgkin (3) · Myelodysplastic Syndromes (3) · Hodgkin Disease (2) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma (2) · Anemia, Aplastic (1) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Bone Marrow Diseases (3) · Leukemia, Myeloid (3) · Chronic Disease (2) · Disease Attributes (2) · Leukemia (2) · Leukemia, B-Cell (2)
Cyclophosphamide (2) · Cytarabine (2) · Etoposide (2) · Melphalan (2) · fludarabine (2) · Busulfan (1) · Carmustine (1) · Clofarabine (1) · Dasatinib (1) · Daunorubicin (1) · Hydrocortisone (1) · Leucovorin (1) · Methotrexate (1) · Mycophenolic Acid (1) · Prednisone (1)
Loyola University (1) · Texas Oncology Cancer Center (1) · University of California, San Diego (1) · Weill Medical College of Cornell University (1)
United States (4)
James K Mangan, MD, PhD (1) · Koen van Besien, MD, PhD (1) · Seah Lim, MD (1) · Zeina Al-Mansour, MD (1)